Funded Project Details - FY2021
|Title:|| Macrophage-Mediated Gene Delivery of Neurotrophic Factors in Parkinson's Disease|
||San Antonio, TX
|Congressional District Code:
||Biomedical Laboratory R&D
|| July 2021 -
|FY 2021 Funding Amount:
|Total Award Amount
View full abstract and other project information on NIH RePORTER
Go To NIH RePORTER
Abstract The development of a neuroprotective therapy for Parkinson's disease (PD) would be a major therapeutic advance, particularly for our veterans. Glial cell line-derived neurotrophic factor (GDNF) has been shown to be the most potent protective trophic molecule to dopamine (DA) neurons affected in PD. GDNF requires CNS delivery as it does not cross the blood-brain barrier (BBB). Unfortunately, clinical trials of GDNF therapy in PD patients have given mixed results. It is challenging to del...
Questions about the R&D website? Email the Web Team
Any health information on this website is strictly for informational purposes and is not intended as medical advice. It should not be used to diagnose or treat any condition.